Minireviews
Copyright ©The Author(s) 2016.
World J Rheumatol. Mar 12, 2016; 6(1): 16-22
Published online Mar 12, 2016. doi: 10.5499/wjr.v6.i1.16
Table 1 Altered expression of RP105 (CD180) and the human and murine diseases
HumanDiseaseRef.
Increased RP105-negative B cells
SLE[8]
ANA-negative SLE[48]
Sjögren’s syndrome[56,57]
Dermatomyositis[58]
IgG4-related disease[13]
ANCA-associated vasculitis[submitted]
Neuromyelitis optica[10]
Aging[64]
Increased RP105-negative B cells; low levels
Rheumatoid arthritis[56]
Systemic sclerosis[56]
Behçet's disease[56]
Mixed connective tissue disease[56]
Polymyositis[56]
Increased RP105 on B cells
Kawasaki disease[63]
Decreased RP105 on stimulated monocytes
Primary biliary cirrhosis[65]
BWF1[52]